Copyright

Additional Metadata
Keywords cholesterol, HMG-CoA reductase inhibitors, PCSK9, pharmacogenetics, rs13064411
Persistent URL dx.doi.org/10.1097/FPC.0000000000000120, hdl.handle.net/1765/88888
Journal Pharmacogenetics and Genomics
Citation
de Keyser, C.E, Becker, M.L, Hofman, A, Lous, J.J, Uitterlinden, A.G, Visser, L.E, & Stricker, B.H.Ch. (2015). The rs13064411 polymorphism in the WDR52 gene, associated with PCSK9 levels, modifies statin-induced changes in serum total and LDL cholesterol levels. Pharmacogenetics and Genomics, 25(3), 134–142. doi:10.1097/FPC.0000000000000120